OLA
CELG

Oliver Luxxe Assets’s Celgene Corp CELG Stock Holding History

Oliver Luxxe Assets’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-12,664
Closed -$1.85M – 88
2017
Q3 		$1.85M Sell
12,664
-344
-3% -$46.9K 1.16% 37
2017
Q2 		$1.69M Buy
13,008
+266
+2% +$32.6K 1.1% 38
2017
Q1 		$1.58M Buy
12,742
+8,617
+209% +$1.03M 1.06% 38
2016
Q4 		$477K Sell
4,125
-127
-3% -$14.1K 0.33% 71
2016
Q3 		$444K Sell
4,252
-35
-0.8% -$3.79K 0.35% 68
2016
Q2 		$423K Sell
4,287
-370
-8% -$38.3K 0.36% 67
2016
Q1 		$466K Hold
4,657
– – 0.48% 55
2015
Q4 		$469K Buy
+4,657
New +$539K 0.42% 68

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Oliver Luxxe Assets's CELG Position: Q4 2017 in Review

Oliver Luxxe Assets sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 12,664 shares — an estimated $1.85M sold.

Oliver Luxxe Assets first reported a position in CELG in Q4 2015 and held it in 8 quarters. The position peaked at $1.85M in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Oliver Luxxe Assets reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Oliver Luxxe Assets sold 12,664 Celgene Corp shares in Q4 2017, an estimated $1.85M.
  • Oliver Luxxe Assets first reported a position in Celgene Corp in Q4 2015 and held it in 8 quarters.
  • Oliver Luxxe Assets's Celgene Corp position peaked at $1.85M in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Oliver Luxxe Assets's 13F filing for Q4 2017, filed 16 Jan 2018.